{ "resourceType" : "Bundle", "id" : "bundlepackageleaflet-en-5af3df1132d20d744a88dab06e924e5e", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"] }, "language" : "en", "identifier" : { "system" : "https://www.gravitatehealth.eu/sid/doc", "value" : "7027e635478c3b3a26b4c7ea7238a57c" }, "type" : "document", "timestamp" : "2023-06-27T10:09:22Z", "entry" : [{ "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-aae8d931abe2f2d9085b87555b9bb088", "resource" : { "resourceType" : "Composition", "id" : "composition-en-aae8d931abe2f2d9085b87555b9bb088", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"] }, "language" : "en", "text" : { "status" : "generated", "div" : "

Generated Narrative: Composition composition-en-aae8d931abe2f2d9085b87555b9bb088

Language: en

Profile: Composition (ePI)

identifier: nan/eb2d55ad5005be64271cb8d7a8411595

status: Final

type: Package Leaflet

category: Raw

date: 2022-02-16 13:28:17+0000

author: Organization Viatris Limited

title: TEST PURPOSES ONLY - Ogivri 150 mg powder for concentrate for solution for infusion

Attesters

-ModeTime
*Official2022-02-16 13:28:17+0000
" }, "identifier" : [{ "system" : "nan", "value" : "eb2d55ad5005be64271cb8d7a8411595" }], "status" : "final", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "Package Leaflet" }, "category" : [{ "coding" : [{ "system" : "http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs", "code" : "R", "display" : "Raw" }] }], "subject" : [{ "reference" : "MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088" }], "date" : "2022-02-16T13:28:17Z", "author" : [{ "reference" : "Organization/mah-5192019d531d0f82a0e8d8ffcb39b68a" }], "title" : "TEST PURPOSES ONLY - Ogivri 150 mg powder for concentrate for solution for infusion ", "attester" : [{ "mode" : { "coding" : [{ "system" : "http://hl7.org/fhir/composition-attestation-mode", "code" : "official" }] }, "time" : "2022-02-16T13:28:17Z" }], "section" : [{ "title" : "B. Package Leaflet", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "B. Package Leaflet" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] }, "section" : [{ "title" : "Package leaflet: Information for the user", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "Package leaflet: Information for the user" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "What is in this leaflet", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "What is in this leaflet" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "1. What 0 is and what it is used for", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "1. What 0 is and what it is used for" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "2. What you need to know before you take 0", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "2. What you need to know before you take 0" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "3. How to take 0", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "3. How to take 0" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "4. Possible side effects", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "4. Possible side effects" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "5. How to store 0", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "5. How to store 0" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }, { "title" : "6. Contents of the pack and other information", "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000155538" }], "text" : "6. Contents of the pack and other information" }, "text" : { "status" : "additional", "div" : "
unavailable
" }, "emptyReason" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason", "code" : "unavailable" }] } }] }] } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-trastuzumab-sorbitol", "resource" : { "resourceType" : "Ingredient", "id" : "ingredient-for-trastuzumab-sorbitol", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: Ingredient ingredient-for-trastuzumab-sorbitol

Profile: Ingredient (ePI)

identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/506T60A25R\u00a0(use:\u00a0official,\u00a0)

status: Active

for:

role: Excipient

substance

Codes

-Concept
*SORBITOL
" }, "identifier" : { "use" : "official", "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta", "value" : "506T60A25R" }, "status" : "active", "for" : [{ "reference" : "ManufacturedItemDefinition/mid-5af3df1132d20d744a88dab06e924e5e" }, { "reference" : "MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088" }, { "reference" : "AdministrableProductDefinition/ap-5af3df1132d20d744a88dab06e924e5e" }], "role" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000072082", "display" : "Excipient" }] }, "substance" : { "code" : { "concept" : { "coding" : [{ "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta", "code" : "506T60A25R", "display" : "SORBITOL" }] } } } } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-trastuzumab-trastuzumab", "resource" : { "resourceType" : "Ingredient", "id" : "ingredient-for-trastuzumab-trastuzumab", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: Ingredient ingredient-for-trastuzumab-trastuzumab

Profile: Ingredient (ePI)

identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/P188ANX8CK\u00a0(use:\u00a0official,\u00a0)

status: Active

for:

role: Active

substance

Codes

-Concept
*trastuzumab

Strengths

-Presentation[x]Basis
*150 mg (Details: UCUM codemg = 'mg')active ingredient - basis of strength
" }, "identifier" : { "use" : "official", "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta", "value" : "P188ANX8CK" }, "status" : "active", "for" : [{ "reference" : "ManufacturedItemDefinition/mid-5af3df1132d20d744a88dab06e924e5e" }, { "reference" : "MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088" }, { "reference" : "AdministrableProductDefinition/ap-5af3df1132d20d744a88dab06e924e5e" }], "role" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000072072", "display" : "Active" }] }, "substance" : { "code" : { "concept" : { "coding" : [{ "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta", "code" : "P188ANX8CK", "display" : "trastuzumab" }] } }, "strength" : [{ "presentationQuantity" : { "value" : 150, "system" : "http://unitsofmeasure.org", "code" : "mg" }, "basis" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass", "code" : "ACTIB", "display" : "active ingredient - basis of strength" }] } }] } } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-trastuzumab", "resource" : { "resourceType" : "SubstanceDefinition", "id" : "substance-trastuzumab", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: SubstanceDefinition substance-trastuzumab

Profile: SubstanceDefinition (ePI)

identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//P188ANX8CK\u00a0(use:\u00a0official,\u00a0)

status: Active

manufacturer: Organization Viatris Limited

" }, "identifier" : [{ "use" : "official", "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value" : "P188ANX8CK" }], "status" : { "coding" : [{ "system" : "http://hl7.org/fhir/publication-status", "code" : "active" }] }, "manufacturer" : [{ "reference" : "Organization/mah-5192019d531d0f82a0e8d8ffcb39b68a" }] } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-5af3df1132d20d744a88dab06e924e5e", "resource" : { "resourceType" : "AdministrableProductDefinition", "id" : "ap-5af3df1132d20d744a88dab06e924e5e", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: AdministrableProductDefinition ap-5af3df1132d20d744a88dab06e924e5e

Profile: AdministrableProductDefinition (ePI)

identifier: https://spor.ema.europa.eu/pmswi/id

status: Active

formOf: MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid/4#7532F47F36A3585D1F348BBDDA057862; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription

administrableDoseForm: Solution for injection

unitOfPresentation: Vial

producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1341/001\u00a0(use:\u00a0official,\u00a0); status = active; manufacturedDoseForm = Powder for concentrate for solution for infusion; unitOfPresentation = Vial

routeOfAdministration

code: Intravenous use

TargetSpecies

-Code
*Human
" }, "identifier" : [{ "system" : "https://spor.ema.europa.eu/pmswi", "value" : "id" }], "status" : "active", "formOf" : [{ "reference" : "MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088" }], "administrableDoseForm" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000073863", "display" : "Solution for injection" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "200000002158", "display" : "Vial" }] }, "producedFrom" : [{ "reference" : "ManufacturedItemDefinition/mid-5af3df1132d20d744a88dab06e924e5e" }], "routeOfAdministration" : [{ "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000073611", "display" : "Intravenous use" }] }, "targetSpecies" : [{ "code" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000109093", "display" : "Human" }] } }] }] } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorization5af3df1132d20d744a88dab06e924e5e0", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "authorization5af3df1132d20d744a88dab06e924e5e0", "text" : { "status" : "generated", "div" : "

Generated Narrative: RegulatedAuthorization authorization5af3df1132d20d744a88dab06e924e5e0

identifier: https://spor.ema.europa.eu/pmswi/EU/1/18/1341/001\u00a0(use:\u00a0official,\u00a0)

subject: MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid/4#7532F47F36A3585D1F348BBDDA057862; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription

type: Marketing Authorisation

status: Active

statusDate: 2018-12-12 00:00:00+0000

holder: Organization Viatris Limited

" }, "identifier" : [{ "use" : "official", "system" : "https://spor.ema.europa.eu/pmswi", "value" : "EU/1/18/1341/001" }], "subject" : [{ "reference" : "MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088" }], "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "220000000061", "display" : "Marketing Authorisation" }] }, "status" : { "coding" : [{ "system" : "http://hl7.org/fhir/publication-status", "code" : "active", "display" : "Active" }] }, "statusDate" : "2018-12-12T00:00:00Z", "holder" : { "reference" : "Organization/mah-5192019d531d0f82a0e8d8ffcb39b68a" } } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-5192019d531d0f82a0e8d8ffcb39b68a", "resource" : { "resourceType" : "Organization", "id" : "mah-5192019d531d0f82a0e8d8ffcb39b68a", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: Organization mah-5192019d531d0f82a0e8d8ffcb39b68a

Profile: Organization (ePI)

identifier: https://spor.ema.europa.eu/omswi/ORG-100034260\u00a0(use:\u00a0official,\u00a0)

active: true

type: Marketing authorisation holder

name: Viatris Limited

Contacts

-Address
*Damastown Industrial Park, Mulhuddart, Dublin 15 Dublin IR(work)
" }, "identifier" : [{ "use" : "official", "system" : "https://spor.ema.europa.eu/omswi", "value" : "ORG-100034260" }], "active" : true, "type" : [{ "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "220000000034", "display" : "Marketing authorisation holder" }] }], "name" : "Viatris Limited", "contact" : [{ "address" : { "use" : "work", "type" : "physical", "text" : "Damastown Industrial Park, Mulhuddart, Dublin 15 Dublin IR", "line" : ["Damastown Industrial Park, Mulhuddart, Dublin 15"], "city" : "Dublin", "country" : "IR" } }] } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-e7c391536e9fc6ff50198d09558da8c0", "resource" : { "resourceType" : "PackagedProductDefinition", "id" : "ppd-e7c391536e9fc6ff50198d09558da8c0", "text" : { "status" : "generated", "div" : "

Generated Narrative: PackagedProductDefinition ppd-e7c391536e9fc6ff50198d09558da8c0

identifier: https://spor.ema.europa.eu/pmswi/EU/1/18/1341/001\u00a0(use:\u00a0official,\u00a0)

name: Ogivri 150 mg powder for concentrate for solution for infusion 1

type: Chemical Medicinal Product

packageFor: MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid/4#7532F47F36A3585D1F348BBDDA057862; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription

status: Active

statusDate: 2015-02-07 13:28:17+0000

containedItemQuantity: 150 mg (Details: UCUM codemg = 'mg')

packaging

type: Box

quantity: 1

material: Cardboard

packaging

identifier: https://spor.ema.europa.eu/pmswi/123456

type: Vial

quantity: 1

material: Glass type I

containedItem

Items

-Reference
*ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#EU/1/18/1341/001\u00a0(use:\u00a0official,\u00a0); status = active; manufacturedDoseForm = Powder for concentrate for solution for infusion; unitOfPresentation = Vial
" }, "identifier" : [{ "use" : "official", "system" : "https://spor.ema.europa.eu/pmswi", "value" : "EU/1/18/1341/001" }], "name" : "Ogivri 150 mg powder for concentrate for solution for infusion 1", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000155527", "display" : "Chemical Medicinal Product" }] }, "packageFor" : [{ "reference" : "MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088" }], "status" : { "coding" : [{ "system" : "http://hl7.org/fhir/publication-status", "code" : "active", "display" : "Active" }] }, "statusDate" : "2015-02-07T13:28:17Z", "containedItemQuantity" : [{ "value" : 150, "system" : "http://unitsofmeasure.org", "code" : "mg" }], "packaging" : { "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000073498", "display" : "Box" }] }, "quantity" : 1, "material" : [{ "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "200000003529", "display" : "Cardboard" }] }], "packaging" : [{ "identifier" : [{ "system" : "https://spor.ema.europa.eu/pmswi", "value" : "123456" }], "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000073563", "display" : "Vial" }] }, "quantity" : 1, "material" : [{ "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "200000003204", "display" : "Glass type I" }] }], "containedItem" : [{ "item" : { "reference" : { "reference" : "ManufacturedItemDefinition/mid-5af3df1132d20d744a88dab06e924e5e" } } }] }] } } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mpaae8d931abe2f2d9085b87555b9bb088", "resource" : { "resourceType" : "MedicinalProductDefinition", "id" : "mpaae8d931abe2f2d9085b87555b9bb088", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: MedicinalProductDefinition mpaae8d931abe2f2d9085b87555b9bb088

Profile: MedicinalProductDefinition (ePI)

identifier: https://www.who-umc.org/phpid/4/7532F47F36A3585D1F348BBDDA057862

type: Medicinal Product

domain: Human use

status: active

legalStatusOfSupply: Medicinal product subject to medical prescription

name

productName: Ogivri 150 mg powder for concentrate for solution for infusion

type: Full name

part

part: Ogivri

type: Invented name part

part

part: trastuzumab

type: Scientific name part

part

part: 150 mg

type: Strength part

part

part: powder for concentrate for solution for infusion

type: Pharmaceutical dose form part

Usages

-CountryJurisdictionLanguage
*NorwayNorwayEnglish
" }, "identifier" : [{ "system" : "https://www.who-umc.org/phpid/4", "value" : "7532F47F36A3585D1F348BBDDA057862" }], "type" : { "coding" : [{ "system" : "http://hl7.org/fhir/medicinal-product-type", "code" : "MedicinalProduct", "display" : "Medicinal Product" }] }, "domain" : { "coding" : [{ "system" : "http://hl7.org/fhir/medicinal-product-domain", "code" : "Human", "display" : "Human use" }] }, "status" : { "coding" : [{ "system" : "http://hl7.org/fhir/publication-status", "code" : "active", "display" : "active" }] }, "legalStatusOfSupply" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "100000072084", "display" : "Medicinal product subject to medical prescription" }] }, "name" : [{ "productName" : "Ogivri 150 mg powder for concentrate for solution for infusion", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/lists/220000000000", "code" : "220000000001", "display" : "Full name" }] }, "part" : [{ "part" : "Ogivri", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/lists/220000000000", "code" : "220000000002", "display" : "Invented name part" }] } }, { "part" : "trastuzumab", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/lists/220000000000", "code" : "220000000003", "display" : "Scientific name part" }] } }, { "part" : "150 mg", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/lists/220000000000", "code" : "220000000004", "display" : "Strength part" }] } }, { "part" : "powder for concentrate for solution for infusion", "type" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/lists/220000000000", "code" : "220000000005", "display" : "Pharmaceutical dose form part" }] } }], "usage" : [{ "country" : { "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "NOR", "display" : "Norway" }] }, "jurisdiction" : { "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "NOR", "display" : "Norway" }] }, "language" : { "coding" : [{ "system" : "urn:ietf:bcp:47", "code" : "en", "display" : "English" }] } }] }] } }, { "fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-5af3df1132d20d744a88dab06e924e5e", "resource" : { "resourceType" : "ManufacturedItemDefinition", "id" : "mid-5af3df1132d20d744a88dab06e924e5e", "meta" : { "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: ManufacturedItemDefinition mid-5af3df1132d20d744a88dab06e924e5e

Profile: ManufacturedItemDefinition (ePI)

identifier: https://spor.ema.europa.eu/pmswi/EU/1/18/1341/001\u00a0(use:\u00a0official,\u00a0)

status: Active

manufacturedDoseForm: Powder for concentrate for solution for infusion

unitOfPresentation: Vial

" }, "identifier" : [{ "use" : "official", "system" : "https://spor.ema.europa.eu/pmswi", "value" : "EU/1/18/1341/001" }], "status" : "active", "manufacturedDoseForm" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi/", "code" : "100000074029", "display" : "Powder for concentrate for solution for infusion" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "https://spor.ema.europa.eu/rmswi", "code" : "200000002158", "display" : "Vial" }] } } }] }